980 likes | 1.28k Views
Campaign to Prevent Antimicrobial Resistance. Centers for Disease Control and Prevention National Center for Infectious Diseases Division of Healthcare Quality Promotion. Clinicians hold the solution!. Link to: Campaign to Prevent Antimicrobial Resistance Online
E N D
Campaign to PreventAntimicrobial Resistance Centers for Disease Control and Prevention National Center for Infectious Diseases Division of Healthcare Quality Promotion Clinicians hold the solution! • Link to: Campaign to Prevent Antimicrobial Resistance Online • Link to:Federal Action Plan to Combat Antimicrobial Resistance
Campaign to Prevent Antimicrobial Resistance in Healthcare Settings 12 Break the chain 11 Isolate the pathogen 10 Stop treatment when cured 9 Know when to say “no” to vanco 8 Treat infection, not colonization 7 Treat infection, not contamination 6 Use local data 5 Practice antimicrobial control 4 Access the experts 3 Target the pathogen 2 Get the catheters out 1 Vaccinate Prevent Transmission Use Antimicrobials Wisely Diagnose & Treat Effectively Prevent Infections 12 Steps to Prevent Antimicrobial Resistance:Hospitalized Adults
12 Steps to Prevent Antimicrobial Resistance: Hospitalized Adults Use Antimicrobials Wisely Step 5: Practice antimicrobial control Fact:Programs to improve antimicrobial use are effective.
12 Steps to Prevent Antimicrobial Resistance: Hospitalized Adults Step 5: Practice antimicrobial control Methods to Improve Antimicrobial Use • Passive prescriber education • Standardized antimicrobial order forms • Formulary restrictions • Prior approval to start/continue • Pharmacy substitution or switch • Multidisciplinary drug utilization evaluation (DUE) • Interactive prescriber education Effective and Increasingly Used Resource intensive up front • Link to:SHEA / IDSA: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals
Multi-prong approaches Abx management teams Computerized systems
Hospitalwide Program • Bantar, CID, 2003 • ASP • ID MD • Clin Microbiologist • Lab Microbiologist • 2 Pharmacists • IM MD • No formulary restrictions
Hospitalwide Program • 4 step intervention phased in every 6 mos • Optional Antibiotic order forms • Mandatory Abx forms with feedback • Review of every Abx order and education • Modification by AMT if necessary • Goal • Decrease 3rd gen Ceph • Increase BL/Blase inhibitor
Hospitalwide Program Iams Vanco Icfp Iams Carb
Hospitalwide Program • Cost savings occur most with mandatory ordering forms
Hospitalwide Program • Cost savings occur most with mandatory ordering forms BUT • Impact in resistance did not occur until full program in place
Computerized Program • Pestotnik, Annals IM, 1996 • Evans, NEJM, 1998 • LDS hospital • Computerized guidelines • Development 1986-1994 • Intergrated information • History • Labs • Cultures • Guidelines • Abx choices • Abx dosing • Abx duration
Outcomes 76 % few adverse drug events
Carling, 2003 • Boston community hospital • ASP program • Outcomes • Costs • Rates of C. difficile/ R GNR infection • Antibiogram vs. NNIS data
Carling, 2003 VRE
Carling, 2003 • Impact of ASP long-lasting • Costs • Nosocomial pathogens • Ability to handle new resistant pathogens
HCSD Beginnings • Data • Pharmacy and Utilization from ILH and HCSD systems offices • MDRO from ILH and HCSD Quality Compass • ILH team • Xavier PharmD faculty (Brakta, Johnson, Bryant, Al-Dahir) • ILH Pharmacy (Cardwell, Terry) • ILH IC (Friloux, Bergeron) • ILH Microbiology Lab (Wall) • HCSD Pharmacy (Jackson) • ID/IC Faculty (Hull, Maffei, Figueroa) • CCM Faculty (deBoisBlanc) • HCSD ASP committee • ID chair (Brown) • Similar personnel from other HCSD facilities
Beginnings • Evaluation of drug costs and utilization • Evaluation of length of stay • Review and evaluation of order sets and protocols • Evaluation of distribution of leading diagnoses • Review of antibiograms and MDRO rates
Next Steps for ILH • Implementation of cellulitis protocol • Daily review of broad spectrum Abx with de-escalation recommendations • Prolonged beta-lactam dosing • COPD/asthma protocol • Limited microbiology Abx reporting • Pharmacokinetic service for vancomycin and aminoglycosides
Outcomes tracked • Broad spectrum Abx use • Length of stay for infectious disease diagnoses • MDRO rates
3rd gen Ceph Restriction • Empey, 2002 • 1999 formulary change • Cefepime for 3rd gen C • Encourage BL/Blase combo • Vanco 72 hr stop • Retrospective • Antibiogram 6 mos before and after change